415 related articles for article (PubMed ID: 35096487)
21. Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells.
Qiu Z; Zhao L; Shen JZ; Liang Z; Wu Q; Yang K; Min L; Gimple RC; Yang Q; Bhargava S; Jin C; Kim C; Hinz D; Dixit D; Bernatchez JA; Prager BC; Zhang G; Dong Z; Lv D; Wang X; Kim LJY; Zhu Z; Jones KA; Zheng Y; Wang X; Siqueira-Neto JL; Chavez L; Fu XD; Spruck C; Rich JN
Cancer Discov; 2022 Feb; 12(2):502-521. PubMed ID: 34615656
[TBL] [Abstract][Full Text] [Related]
22. Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma.
Sun Z; Zhao Y; Wei Y; Ding X; Tan C; Wang C
Front Immunol; 2022; 13():939523. PubMed ID: 36091049
[TBL] [Abstract][Full Text] [Related]
23. The immune cell landscape of glioblastoma patients highlights a myeloid-enriched and immune suppressed microenvironment compared to metastatic brain tumors.
Musca B; Russo MG; Tushe A; Magri S; Battaggia G; Pinton L; Bonaudo C; Della Puppa A; Mandruzzato S
Front Immunol; 2023; 14():1236824. PubMed ID: 37936683
[TBL] [Abstract][Full Text] [Related]
24. Myeloid Cells in Glioblastoma Microenvironment.
De Leo A; Ugolini A; Veglia F
Cells; 2020 Dec; 10(1):. PubMed ID: 33374253
[TBL] [Abstract][Full Text] [Related]
25. The Heterogeneity of Tumour-Associated Macrophages Contributes to the Recurrence and Outcomes of Glioblastoma Patients.
Xuan Z; Fang L; Zhang G; Zhang X; Jiang J; Wang K; Huang P
J Mol Neurosci; 2023 Jan; 73(1):1-14. PubMed ID: 36542317
[TBL] [Abstract][Full Text] [Related]
26. Transcriptome and single-cell analysis reveal the contribution of immunosuppressive microenvironment for promoting glioblastoma progression.
Ni L; Sun P; Zhang S; Qian B; Chen X; Xiong M; Li B
Front Immunol; 2022; 13():1051701. PubMed ID: 36685556
[TBL] [Abstract][Full Text] [Related]
27. Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy.
White K; Connor K; Meylan M; Bougoüin A; Salvucci M; Bielle F; O'Farrell AC; Sweeney K; Weng L; Bergers G; Dicker P; Ashley DM; Lipp ES; Low JT; Zhao J; Wen P; Prins R; Verreault M; Idbaih A; Biswas A; Prehn JHM; Lambrechts D; Arijs I; Lodi F; Dilcan G; Lamfers M; Leenstra S; Fabro F; Ntafoulis I; Kros JM; Cryan J; Brett F; Quissac E; Beausang A; MacNally S; O'Halloran P; Clerkin J; Bacon O; Kremer A; Chi Yen RT; Varn FS; Verhaak RGW; Sautès-Fridman C; Fridman WH; Byrne AT
Ann Oncol; 2023 Mar; 34(3):300-314. PubMed ID: 36494005
[TBL] [Abstract][Full Text] [Related]
28. Characterization of Different Subtypes of Immune Cell Infiltration in Glioblastoma to Aid Immunotherapy.
Feng P; Li Z; Li Y; Zhang Y; Miao X
Front Immunol; 2022; 13():799509. PubMed ID: 35799789
[TBL] [Abstract][Full Text] [Related]
29. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
[TBL] [Abstract][Full Text] [Related]
30. Computational Characterization of Suppressive Immune Microenvironments in Glioblastoma.
Luoto S; Hermelo I; Vuorinen EM; Hannus P; Kesseli J; Nykter M; Granberg KJ
Cancer Res; 2018 Oct; 78(19):5574-5585. PubMed ID: 29921698
[TBL] [Abstract][Full Text] [Related]
31. Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy.
Cui X; Ma C; Vasudevaraja V; Serrano J; Tong J; Peng Y; Delorenzo M; Shen G; Frenster J; Morales RT; Qian W; Tsirigos A; Chi AS; Jain R; Kurz SC; Sulman EP; Placantonakis DG; Snuderl M; Chen W
Elife; 2020 Sep; 9():. PubMed ID: 32909947
[TBL] [Abstract][Full Text] [Related]
32. Revealing and Harnessing Tumour-Associated Microglia/Macrophage Heterogeneity in Glioblastoma.
Pires-Afonso Y; Niclou SP; Michelucci A
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973030
[No Abstract] [Full Text] [Related]
33. Driver Mutations Dictate the Immunologic Landscape and Response to Checkpoint Immunotherapy of Glioblastoma.
Yeo AT; Shah R; Aliazis K; Pal R; Xu T; Zhang P; Rawal S; Rose CM; Varn FS; Appleman VA; Yoon J; Varma H; Gygi SP; Verhaak RGW; Boussiotis VA; Charest A
Cancer Immunol Res; 2023 May; 11(5):629-645. PubMed ID: 36881002
[TBL] [Abstract][Full Text] [Related]
34. Integrated single-cell transcriptomic analyses reveal that GPNMB-high macrophages promote PN-MES transition and impede T cell activation in GBM.
Xiong A; Zhang J; Chen Y; Zhang Y; Yang F
EBioMedicine; 2022 Sep; 83():104239. PubMed ID: 36054938
[TBL] [Abstract][Full Text] [Related]
35. Immune microenvironments differ in immune characteristics and outcome of glioblastoma multiforme.
Zhang B; Shen R; Cheng S; Feng L
Cancer Med; 2019 Jun; 8(6):2897-2907. PubMed ID: 31038851
[TBL] [Abstract][Full Text] [Related]
36. Classification of Glioblastoma Associated with Immune Checkpoints and Tumor Microenvironment based on Immunogenomic Profiling.
Zheng P; Zhang X; Ren D; Bai Q
Neurol India; 2024 Mar; 72(2):297-303. PubMed ID: 38691473
[TBL] [Abstract][Full Text] [Related]
37. A novel defined risk signature of interferon response genes predicts the prognosis and correlates with immune infiltration in glioblastoma.
Xiao Y; Wang Z; Zhao M; Ji W; Xiang C; Li T; Wang R; Yang K; Qian C; Tang X; Xiao H; Zou Y; Liu H
Math Biosci Eng; 2022 Jun; 19(9):9481-9504. PubMed ID: 35942769
[TBL] [Abstract][Full Text] [Related]
38. Immune landscape-based machine-learning-assisted subclassification, prognosis, and immunotherapy prediction for glioblastoma.
Li H; He J; Li M; Li K; Pu X; Guo Y
Front Immunol; 2022; 13():1027631. PubMed ID: 36532035
[TBL] [Abstract][Full Text] [Related]
39. Immune microenvironment of experimental rat C6 gliomas resembles human glioblastomas.
Gieryng A; Pszczolkowska D; Bocian K; Dabrowski M; Rajan WD; Kloss M; Mieczkowski J; Kaminska B
Sci Rep; 2017 Dec; 7(1):17556. PubMed ID: 29242629
[TBL] [Abstract][Full Text] [Related]
40. The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma.
Goenka A; Tiek D; Song X; Huang T; Hu B; Cheng SY
Cells; 2021 Feb; 10(3):. PubMed ID: 33668200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
